Niagen Bioscience Inc (NAGE) delivered a return of -75.58% over the past year. Since NAGE does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Niagen Bioscience Inc one year ago would be worth $2,442 today, representing a loss of $7,558.

Niagen Bioscience Inc (NAGE) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For NAGE, the total return equals the price-only return.

No, Niagen Bioscience Inc (NAGE) underperformed the S&P 500 by 96.43 percentage points over the past year. NAGE delivered a total return of -75.58%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed NAGE by 96.43pp during this period.

Niagen Bioscience Inc (NAGE) experienced a maximum drawdown of -77.03% over the past year, declining from its peak on 2025-06-30 to its trough on 2026-06-08. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Niagen Bioscience Inc (NAGE)'s long-term returns with dividends reinvested. Over 10 years, the total return is 19.4% (1.8% CAGR) — $10,000 would have grown to $11,938. Over 20 years: -70.5% total return (-5.9% CAGR) — $10,000 → $2,949. Over 30 years: -70.5% total return (-4.0% CAGR) — $10,000 → $2,949. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Niagen Bioscience Inc's best calendar year was 2024 with a total return of 271.3%. Its worst year was 2008 with a total return of -70.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 341.3 percentage points.